April 23, 2025
NEW Approved Treatment for Prader-Willi syndrome
The FDA has recently approved Vykat XR (diazoxide choline) extended-release tablets for the treatment of hyperphagia, or persistent hunger, in individuals with Prader-Willi syndrome (PWS) aged 4 and older. This is the first FDA-approved treatment for this diagnosis. It is administered via a once-daily, extended-release tablet . The drug is approved for individuals with PWS aged 4 years and older who...
